References
- Lai SW. Letter to the Editor: trends in varicella epidemiology before and after the implementation of universal one-dose varicella vccination. Human Vaccines & Immunotherapeutics. 2019. doi:10.1080/21645515.2019.1633879.
- Choi JK, Park SH, Park S, Choi SM, Kim SH, Lee DG, Yoo JH, Choi JH, Kang JH. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003–2015. Hum Vaccin Immunother. 2019:1–7. doi:10.1080/21645515.2019.1603985.
- Cheng HY, Chang LY, Lu CY, Huang LM. Epidemiology of breakthrough varicella after the implementation of a universal varicella vaccination program in Taiwan, 2004–2014. Sci Rep. 2018;8(1):17192. doi:10.1038/s41598-018-35451-y.
- Wilder-Smith A, Longini I, Zuber PL, Barnighausen T, Edmunds WJ, Dean N, Spicher VM, Benissa MR, Gessner BD. The public health value of vaccines beyond efficacy: methods, measures and outcomes. BMC Med. 2017;15(1):138. doi:10.1186/s12916-017-0911-8.
- Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007;25(45):7866–72. doi:10.1016/j.vaccine.2007.07.036.
- Lee H, Cho HK, Kim KH. Seroepidemiology of varicella-zoster virus in Korea. J Korean Med Sci. 2013;28(2):195–99. doi:10.3346/jkms.2013.28.2.195.
- Tseng HF, Tan HF, Chang CK, Wang LY, Yang SE, Liau MY, Chen CY, Huang SP. A seroepidemiology study of varicella among children aged 0–12 years in Taiwan. Southeast Asian J Trop Med Public Health. 2005;36:1201–07.
- Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: A meta-analysis. Pediatrics. 2016;137(3):e20153741. doi:10.1542/peds.2015-3741.
- Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis. 2008;197(7):944–49. doi:10.1086/529043.
- Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, Seward JF. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356(11):1121–29. doi:10.1056/NEJMoa064040.
- Choi UY, Huh DH, Kim JH, Kang JH. Seropositivity of varicella zoster virus in vaccinated Korean children and MAV vaccine group. Hum Vaccin Immunother. 2016;12(10):2560–64. doi:10.1080/21645515.2016.1190056.
- Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010;28(19):3385–97. doi:10.1016/j.vaccine.2010.02.079.
- Gao Z, Gidding HF, Wood JG, MacIntyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010;138(4):457–68. doi:10.1017/S0950268809990860.